Beleave and Dr. Mohit Bhandari Begin Clinical Research Program to Investigate Therapeutic Use of Cannabinoids for Musculoskeletal Disorders
April 26, 2017 07:30 ET
|
Beleave Inc.
TORONTO, ON--(Marketwired - April 26, 2017) - Beleave Inc. ("Beleave") (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it will begin a clinical research program with Dr. Mohit...
Beleave and Ryerson University Continue Research and Development of Industrial Processes
March 06, 2017 07:00 ET
|
Beleave Inc.
TORONTO, ON--(Marketwired - March 06, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it is now beginning work on a second drug...
Beleave and Ryerson University Collaborator Begin Patent Work by Expanding on Recent Genetic Results
February 08, 2017 07:00 ET
|
Beleave Inc.;Ryerson University;NSERC
TORONTO, ON--(Marketwired - February 08, 2017) - Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it will begin a collaborative research project with Dr. Lesley Campbell,...
Beleave Completes Facility Build Out and Upgrades in Advance of Future Expansion
January 12, 2017 07:30 ET
|
Beleave Inc.
TORONTO, ON--(Marketwired - January 12, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) is pleased to announce that after receiving its affirmation letter, as announced September 26,...
Beleave and Ryerson Develop Unique Approach for Cannabinoid Extraction and Recovery
December 14, 2016 08:27 ET
|
Beleave Inc.;Ryerson University;NSERC
TORONTO, ON--(Marketwired - December 14, 2016) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) is pleased to announce that it has successfully completed a Natural Sciences and Engineering...
Beleave Provides Business Update
September 26, 2016 07:30 ET
|
Beleave Inc.
TORONTO, ON--(Marketwired - September 26, 2016) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) is pleased to announce that it has received notification from Health Canada that, upon the...
Beleave Appoints Retired Lieutenant Colonel Dana Gidlow as Head of Veteran Affairs and Community Outreach
June 16, 2016 08:00 ET
|
Beleave Inc.
TORONTO, June 16, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce the addition of retired Lieutenant Colonel Dana Gidlow as the company’s Head of...
Beleave Announces the Addition of Former Drug Prosecutor Chris Murphy to the Team
June 15, 2016 08:00 ET
|
Beleave Inc.
TORONTO, June 15, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce that Chris Murphy B.A., M.A., LL.B. will be added to the...
Beleave Strengthens Advisory Board With Addition of Andrew Steane
May 03, 2016 10:54 ET
|
Beleave Inc.
TORONTO, May 03, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce that Andrew Steane will be added to the company’s Advisory Board. With over 20...
Beleave Signs Letter of Intent With gDial Inc. Regarding Proprietary Drug Dosing, Detection, and Usage-Tracking Technology
April 18, 2016 09:05 ET
|
Beleave Inc.
TORONTO, ON--(Marketwired - April 18, 2016) -
Beleave Inc.
(CSE: BE) ("Beleave" or the "Company") is pleased to announce that it has entered into a letter of intent ("LOI") to pursue a...